0000939767-20-000083.txt : 20200515
0000939767-20-000083.hdr.sgml : 20200515
20200515202049
ACCESSION NUMBER: 0000939767-20-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200513
FILED AS OF DATE: 20200515
DATE AS OF CHANGE: 20200515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hessekiel Jeffrey
CENTRAL INDEX KEY: 0001599803
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 20887472
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_158958843032722.xml
FORM 4
X0306
4
2020-05-13
0
0000939767
EXELIXIS, INC.
EXEL
0001599803
Hessekiel Jeffrey
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
0
1
0
0
EVP and General Counsel
Common Stock
2020-05-13
4
M
0
25000
1.70
A
264188
D
Common Stock
2020-05-13
4
F
0
13875
26.53
D
250313
D
Common Stock
999
I
By 401(k)
Option (right to buy)
1.7
2020-05-13
4
M
0
25000
0
D
2015-07-20
2021-09-18
Common Stock
25000.0
0
D
Includes 36,559 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents a "net exercise" of an outstanding stock option. The Reporting Person received 11,125 shares of Common Stock on the net exercise of a stock option to purchase 25,000 shares of Common Stock. The Issuer withheld 13,875 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 13, 2020 of $26.53.
Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 13, 2020.
The option, representing the right to purchase a total of 400,000 shares of Common Stock, became fully exercisable on April 28, 2016.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2020-05-15